TM Owner Pfizer
Trumenba 120mcg/0.5ml Injection
Global Shipping : Reliable Global Distribution Network
Express Delivery : Priority Shipping for Every Order
Secure Payments : Trusted Payment Protection System
Disclaimer
Secure Handling
24/7 Worldwide Support
Global Access
Worldwide Access to Health
Cold-Chain Expert
Excellence in Cold-Chain
Trusted Supply
Certified Medical Supply
Indications & Clinical Uses
- Trumenba is a recombinant meningococcal group B vaccine containing lipidated factor H binding protein (fHbp) from both subfamily A and subfamily B strains of Neisseria meningitidis serogroup B, given as a 0.5 mL intramuscular injection.
- It is approved in the United States for active immunization to prevent invasive meningococcal disease caused by serogroup B in individuals 10 through 25 years of age, given as either a 2-dose series (0 and 6 months) or a 3-dose series (0, 1 to 2 months, and 6 months) depending on risk and schedule flexibility needed.
- Trumenba does not protect against meningococcal disease caused by other serogroups (A, C, W, Y) and is given by a healthcare professional, not self-administered.
- It is manufactured by Wyeth (a Pfizer company).
Side Effects
- Trumenba has no boxed warning on its current US label.
- The most common reactions, each affecting more than half of recipients, are pain, redness or swelling at the injection site, fatigue, headache and muscle pain (myalgia); chills, joint pain and diarrhea are also reported.
- These effects are usually mild to moderate and resolve within a few days.
- As with any vaccine, seek urgent medical care for signs of a severe allergic reaction such as difficulty breathing, swelling of the face or throat, hives or a fast heartbeat shortly after the injection, and tell the vaccinator immediately if you feel faint, as fainting can follow any injection, especially in adolescents.
Precautions & Warnings
- Trumenba is contraindicated in anyone with a severe allergic reaction to a previous dose or to any vaccine component.
- Vaccination should be postponed in anyone with moderate or severe acute illness until they recover.
- Trumenba may not protect everyone who receives it, and it does not cover meningococcal serogroups other than B, so other recommended vaccines (e.g., MenACWY) are still needed.
- People with weakened immune systems, including those with complement deficiencies or on complement inhibitor therapy, remain at risk of meningococcal disease despite vaccination.
- Discuss use in pregnancy and breastfeeding with your healthcare provider, as data are limited.
- Unopened, unused vaccine is stored refrigerated at 2°C to 8°C and must not be frozen; pre-filled syringes should be stored horizontally.
Avoid Interactions
- Tell the vaccinating healthcare professional about all other vaccines, medicines and supplements being taken, including any immunosuppressive treatment or corticosteroids, since these can reduce the immune response to Trumenba.
- Trumenba can be given at the same visit as other age-appropriate vaccines, but each vaccine should be injected at a separate site, generally in a different limb.
- If Trumenba is given with other injectable vaccines or medicines, do not mix them in the same syringe.
- Tell your healthcare provider if you are receiving allergen immunotherapy or any treatment that lowers immune response, as this may reduce vaccine effectiveness.
References
Frequently Asked Questions
Trumenba is a vaccine that protects against invasive meningococcal group B disease, a serious bacterial infection that can cause meningitis or blood poisoning. It is approved for people aged 10 through 25. It does not protect against meningococcal groups A, C, W or Y.
A healthcare professional injects Trumenba into a muscle, usually the upper arm, as either two doses 6 months apart or three doses at 0, 1-2 months and 6 months. It is not self-administered, so there is no missed-dose routine to follow at home.
Most people getting Trumenba have injection-site pain, tiredness, headache or muscle aches that settle within a few days. Trumenba has no boxed warning. Seek emergency care for swelling of the face or throat, difficulty breathing, or fainting shortly after the shot.
No. Trumenba only protects against Neisseria meningitidis serogroup B. It does not cover serogroups A, C, W or Y, so a separate MenACWY vaccine is still recommended on the usual immunization schedule alongside Trumenba.
Anyone who had a severe allergic reaction to a previous Trumenba dose or to any of its ingredients should not receive it again. Vaccination is postponed during moderate or severe acute illness. People with complement deficiencies remain at risk of meningococcal disease even after vaccination.
Yes, Trumenba can be given at the same visit as other vaccines recommended for adolescents and young adults, such as MenACWY or HPV vaccine, but each is injected at a different site. Tell your healthcare provider about immune-suppressing medicines first.
Trusted & Reliable – Your Partner in Global Distribution.
We provide comprehensive lines of pharmaceutical products to support all your healthcare distribution needs.
